EUVIMEDEUVIMED entdecken
Crossref

Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties

Ming Zhang, Yan Chen, Shuaiqi Feng, Yanqin He, Zhifang Liu, Ning Zhang iD, Qingpeng Wang iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Ming Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carbazoles, Epithelial-Mesenchymal Transition, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Liaocheng University, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inflammatory microenvironment is a central driver of tumor metastasis, intimately associated with the promotion of epithelial-mesenchymal transition (EMT) and immune suppression. Here, transferrin-modified carprofen platinum(IV) nanoparticles Tf-NPs@CPF2-Pt(IV) with promising antiproliferative and antimetastatic properties were developed, which activated by inhibiting inflammation, suppressing EMT, and activating immune responses besides causing DNA injury. The nanoparticles released the active ingredient CPF2-Pt(IV) in a sustained manner and offered enhanced pharmacokinetic properties compared to free CPF2-Pt(IV) in vivo. Additionally, they possessed satisfactory tumor targeting effects via the transferrin motif. Serious DNA damage was induced with the upregulation of γ-H2AX and P53, and the mitochondria-mediated apoptotic pathway Bcl-2/Bax/caspase3 was initiated. Inflammation was alleviated by inhibiting COX-2 and MMP9 and decreasing inflammatory cytokines TNF-α and IL-6. Subsequently, the EMT was reversed by inhibiting the Wnt/β-catenin pathway. Furthermore, the antitumor immunity was provoked by blocking the immune checkpoint PD-L1 and increasing CD3+ and CD8+ T lymphocytes in tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCarbazolesEpithelial-Mesenchymal TransitionInflammationTransferrinAnimalsFemaleHumansMaleMiceCell Line, TumorCell ProliferationMetal NanoparticlesMice, Inbred BALB CNanoparticlesNeoplasm MetastasisPlatinumOrganoplatinum Compounds

Substanzen

Antineoplastic AgentsCarbazolescarprofenPlatinumTransferrinOrganoplatinum Compounds

Autor:innen und Institutionen

  • Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P. R. China.
  • Key Laboratory of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, P. R. China.

ORCID-Profile: Ning Zhang, Qingpeng Wang

Förderung

  • Liaocheng University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Youth Innovation Technology Project of Higher School in Shandong Province

Zitieren

APA

Zhang, M., Chen, Y., Feng, S., He, Y., Liu, Z., Zhang, N., & Wang, Q. (2024). Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01265

Vancouver

Zhang M, Chen Y, Feng S, He Y, Liu Z, Zhang N, et al. Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01265

BibTeX
@article{Zhang2024,
  author = {Zhang, Ming and Chen, Yan and Feng, Shuaiqi and He, Yanqin and Liu, Zhifang and Zhang, Ning and Wang, Qingpeng},
  title = {Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01265}
}
Kostenlos starten →